Carlisle Companies (CSL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
17 Mar, 2026Executive summary
The 2026 Annual Meeting will be held on April 29, 2026, with proposals to elect two directors, approve executive compensation for 2025, and ratify Deloitte & Touche LLP as auditor for 2026.
Only shareholders of record as of March 4, 2026, may vote; 40,878,276 shares were outstanding as of the record date.
Voting can be done online, by phone, mail, or in person, with specific instructions for registered, beneficial, and 401(k) plan shareholders.
Voting matters and shareholder proposals
Proposals include electing two directors, advisory approval of 2025 executive compensation, and ratification of Deloitte & Touche LLP as auditor.
Majority vote is required for all proposals; abstentions and broker non-votes are handled per NYSE rules.
Shareholders can submit proposals for the 2027 meeting by November 17, 2026, and director nominations by specific deadlines.
Board of directors and corporate governance
The board consists of eight members, divided into three classes; two directors are up for election for three-year terms.
Board committees include Audit, Compensation, and Corporate Governance and Nominating, each with defined charters and rotating chairs.
All directors except the CEO are independent under NYSE and company standards.
The board emphasizes diversity and has a structured nomination process, including proxy access for significant shareholders.
Lead Independent Director role provides oversight and facilitates communication between independent directors and management.
Latest events from Carlisle Companies
- Vision 2030 aims for $40+ EPS and $400+ share price through innovation and operational excellence.CSL
Investor presentation20 Mar 2026 - Annual meeting to address director elections, executive pay, and auditor ratification.CSL
Proxy Filing17 Mar 2026 - 2025 saw $5.02B revenue, $1.5B returns, and 2026 targets growth and margin expansion.CSL
Q4 20254 Feb 2026 - Q2 saw 11% revenue growth, record margins, and a raised 2024 outlook on strong execution.CSL
Q2 20243 Feb 2026 - Record Q3 EPS and margin gains driven by CCM, with continued capital returns and acquisitions.CSL
Q3 202418 Jan 2026 - Record EPS, margin gains, and strategic acquisitions set up double-digit EPS growth for 2025.CSL
Q4 20249 Jan 2026 - Strong 2024 performance and Vision 2030 strategy drive growth in building envelope solutions.CSL
Investor Presentation8 Jan 2026 - Flat Q1 revenue, robust buybacks, and positive 2025 outlook amid economic uncertainty.CSL
Q1 202520 Dec 2025 - Board recommends FOR all proposals, highlighting governance, pay-for-performance, and diversity.CSL
Proxy Filing1 Dec 2025